Plan every lane with confidence. Make the next one smarter.
Manage pharma supply chain risk against one qualified model. Bring lane, packaging, provider, and SOP decisions together, then use real shipment outcomes to improve the next plan.
The question you own
Will this lane protect the product?
The answer depends on product limits, packaging, and provider performance. Today, that evidence lives in separate places.
Where the handoff breaks
The approved plan stops where execution starts.
A planning tool can hold the route. A supplier form can describe capability. A quality system can hold the SOP. The decision loses context when those records never meet the actual shipment.
Provider evidence
Forms and email
What a vendor saysQualified plan
SOPs and lane files
What should happenLive outcomes
Carrier and release records
What actually happenedNo shared model connects the assumptions to the outcome.
The work you own
You own the plan. The evidence lives everywhere.
A pharma lane is a product protection decision. You need to know whether the route, packaging, provider, and operating procedure work together for the product being shipped.
| Your responsibility | Where work fragments | What the disconnected setup cannot give you |
|---|---|---|
Qualify lanes and providers | Vendor capability forms, packaging evidence, and lane configurations arrive in different formats. Reviews depend on follow-up and manual comparison. | Compare provider and site capabilities consistently, with an attributable approval for the complete lane. |
Choose packaging and routes | Product stability, transit assumptions, and packaging performance sit outside the same planning model. Alternatives are difficult to assess together. | Simulate the trade-offs before committing to a route, carrier, or packaging configuration. |
Keep the qualified plan current | An approved SOP can sit in SharePoint while live performance and disposition outcomes stay in operational systems. | Use actual shipments to update lane risk and inform the next qualification. |
What changes with PAXAFE
Manage pharma supply chain risk with a plan that learns.
Lane Qualification & Active Risk Intelligence connects the evidence before departure and keeps the model alive afterward.
Parse documents and structure vendor and site assessments. Provider memory and communication agents help complete the back-and-forth, so comparisons use a consistent model.
Explore Lane Qualification & Active Risk IntelligenceSimulate supply and distribution options against product, packaging, and operating constraints. Digitized SOPs, review workflows, and Part 11 signatures keep the decision with the qualified configuration.
Explore WorkflowsActive lane risk and Insights return shipment performance to the planning model. Compare plan with actual, identify recurring risks, and refine future provider and packaging choices.
Explore InsightsOne connected record. Every decision traceable.
The value for your team
Less friction.
More confidence in the decision.
✓
More consistent qualification
✓
Evidence-based provider choices
✓
Less over- and under-packaging
✓
A plan that learns from execution
Questions answered
What is the supply chain risk in the pharmaceutical industry?
Pharmaceutical supply chain risk includes delays, unsuitable transport or packaging choices, temperature exposure, inconsistent provider performance, and gaps in the evidence needed for release. Planning teams need to assess these risks against the product’s requirements and the qualified operating model. PAXAFE connects that baseline to actual shipment outcomes so subsequent lane and provider decisions use the network’s accumulated evidence. Explore lane qualification and active risk intelligence.
See it in your operation
See your next lane decision in CONTXT.
Bring a lane, its SOP, and your provider options. We’ll show how qualification, live risk, and shipment outcomes connect.